Effects of ramipril on coronary events in high-risk persons: Results of the heart outcomes prevention evaluation study

Circulation

Volumn 104, Issue 5, 2001, Pages 522-526

  Dagenais, Gilles R ^a   Yusuf, Salim ^b   Bourassa, Martial G ^c   Yi, Qilong ^b   Bosch, Jackie ^b   Lonn, Eva M ^b   Kouz, Simon ^d   Grover, John ^e  

^a LAVAL UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d Centre Hospitalier de Lanaudière   (Canada)

^e PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

Author keywords

Angina; Angiotensin; Coronary disease; Myocardial infarction; Revascularization

Indexed keywords

ALPHA TOCOPHEROL; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PERINDOPRIL; PLACEBO; RAMIPRIL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME INHIBITION; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK BENEFIT ANALYSIS;

EID: 0035979343     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3001.093502     Document Type: Article

References (13)

1. Anti-ischemic effects of ACE-inhibitors: Review of current clinical evidence and ongoing trials
2. Effect of enalapril on myocardial infarction and unstable angina in patients with known low ejection fractions
3. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival of left ventricular enlargement trial
4. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction
5. Long term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: A systematic overview of data from individual patients
6. Effects of captopril on ischemic events after myocardial infarction: Results of the Survival Ventricular Enlargement trial
7. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
8. The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple, randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events
9. Vitamin E supplementation cardiovascular events in high-risk patients
10. Regression models and lifetables
11. Neuroendocrine activity in untreated heart failure
12. Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease
13. Effects of ramipril and of vitamin E on atherosclerosis: Results of randomized study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E